Pursuant to Regulations 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed regarding issue of duplicate share certificates to the Shareholders. Details enclosed.
The above information is a part of company’s filings submitted to BSE.